Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
Soini E, Holmberg M, Asseburg C, Sumelahti ML
Value Health. 2014 Nov; 17(7):A400. PMID: 27200954.Abstract